Long-acting injectable antiretroviral therapy for HIV-1 infection in adults

被引:0
|
作者
Halani, Sheliza [1 ]
Tan, Darrell [1 ,2 ]
Andany, Nisha [1 ,3 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada
关键词
D O I
10.1503/cmaj.231498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E341 / E342
页数:2
相关论文
共 50 条
  • [21] Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application
    Kesteleyn, Bart
    Amssoms, Katie
    Schepens, Wim
    Hache, Geerwin
    Verschueren, Wim
    Van De Vreken, Wim
    Rombauts, Klara
    Meurs, Greet
    Sterkens, Patrick
    Stoops, Bart
    Baert, Lieven
    Austin, Nigel
    Wegner, Jorg
    Masungi, Chantal
    Dierynck, Inge
    Lundgren, Stina
    Jonsson, Daniel
    Parkes, Kevin
    Kalayanov, Genadiy
    Wallberg, Hans
    Rosenquist, Asa
    Samuelsson, Bertil
    Van Emelen, Kristof
    Thuring, Jan Willem
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 310 - 317
  • [22] Considerations for long-acting antiretroviral therapy in older persons with HIV
    OShea, Jesse G.
    Cholli, Preetam
    Heil, Emily L.
    Buchacz, Kate
    AIDS, 2023, 37 (15) : 2271 - 2286
  • [23] Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review
    Jennie E. Johnson
    Amy L. Brotherton
    Michael R. Rossi
    Martha C. Sanchez
    Curt G. Beckwith
    Current HIV/AIDS Reports, 2025, 22 (1)
  • [24] Long-acting injectable antiretroviral therapy: potential solution for postbariatric surgery challenges
    Testa, Jacopo
    Cattaneo, Dario
    Giacomelli, Andrea
    Lai, Alessia
    Ridolfo, Anna Lisa
    Gori, Andrea
    Menzaghi, Barbara
    Gervasoni, Cristina
    AIDS, 2025, 39 (05) : 625 - 626
  • [25] Cabotegravir long-acting for HIV-1 prevention
    Andrews, Chasity D.
    Heneine, Walid
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 258 - 263
  • [26] A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the US
    Simoni, Jane M.
    Tapia, Kenneth
    Lee, Sung-Jae
    Graham, Susan M.
    Beima-Sofie, Kristin
    Mohamed, Zahra H.
    Christodoulou, Joan
    Ho, Rodney
    Collier, Ann C.
    AIDS AND BEHAVIOR, 2020, 24 (04) : 1226 - 1236
  • [27] Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy
    Philbin, Morgan M.
    Parish, Carrigan L.
    Kinnard, Elizabeth N.
    Reed, Sarah E.
    Kerrigan, Deanna
    Alcaide, Maria L.
    Cohen, Mardge H.
    Sosanya, Oluwakemi
    Sheth, Anandi N.
    Adimora, Adaora A.
    Cocohoba, Jennifer
    Goparaju, Lakshmi
    Golub, Elizabeth T.
    Fischl, Margaret
    Metsch, Lisa R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 84 (03) : 263 - 270
  • [28] Reassessing oral lead-in for injectable long-acting HIV therapy
    Llibre, Josep M.
    Sax, Paul E.
    LANCET HIV, 2021, 8 (11): : E660 - E661
  • [29] Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
    Zakumumpa, Henry
    Alinaitwe, Adolf
    Kyomuhendo, Marjorie
    Nakazibwe, Brenda
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [30] French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
    Hoen, Bruno
    Bonnet, Fabrice
    Delaugerre, Constance
    Delobel, Pierre
    Goujard, Cecile
    L'Henaff, Marianne
    Persiaux, Renaud
    Rey, David
    Rouzioux, Christine
    Taburet, Anne-Marie
    Morlat, Philippe
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17